𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Endocannabinoid System and Alzheimer’s Disease

✍ Scribed by Cristina Benito; Estefanía Núñez; María Ruth Pazos; Rosa María Tolón; Julián Romero

Book ID
107582552
Publisher
Springer
Year
2007
Tongue
English
Weight
122 KB
Volume
36
Category
Article
ISSN
0893-7648

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Homeostatic changes of the endocannabino
Homeostatic changes of the endocannabinoid system in Parkinson's disease
✍ Valerio Pisani; Graziella Madeo; Annalisa Tassone; Giuseppe Sciamanna; Mauro Mac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Endocannabinoids (eCBs) are endogenous lipids that bind principally type-1 and type-2 cannabinoid (CB 1 and CB 2 ) receptors. N-Arachidonoylethanolamine (AEA, anandamide) and 2-arachidonoylglycerol (2-AG) are the best characterized eCBs that are released from membrane phospholipid precursors through

Glutamatergic systems in Alzheimer's dis
Glutamatergic systems in Alzheimer's disease
✍ Paul T. Francis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Glutamate is the major transmitter of the brain and is involved in all aspects of cognitive function since it is the transmitter of cortical and hippocampal pyramidal neurones. Furthermore, glutamate and glutamate receptors are involved in long-term potentiation, a process believed to underlie learn

Oestrogens and Alzheimer's disease
Oestrogens and Alzheimer's disease
✍ Martin H. Birkhäuser; Jindrich Strnad; Christian Kämpf; Marcel Bahro 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views
Driving and Alzheimer's disease
Driving and Alzheimer's disease
✍ Harold N. Mozar; James T. Howard 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views